Warfarin sensitivity after mechanical heart valve replacement

J P Rose1, T L Rihn, S F Long

  • 1Department of Pharmacy, Allegheny University Hospitals, Allegheny General, Pittsburgh, Pennsylvania, USA.

Pharmacotherapy
|August 6, 1998
PubMed

Insights

Patients on warfarin post-mechanical heart valve replacement show increased drug sensitivity. Early reduced warfarin dosages may be necessary to manage international normalized ratio (INR) levels safely in these individuals.

Area of Science:

  • Cardiology
  • Pharmacology
  • Medical Research

Background:

  • Warfarin is a common anticoagulant used to prevent thrombosis.
  • Mechanical heart valve replacement necessitates long-term anticoagulation therapy.
  • Understanding warfarin sensitivity is crucial for safe and effective patient management.

Purpose of the Study:

  • To evaluate warfarin sensitivity in patients following mechanical heart valve replacement.
  • To compare international normalized ratio (INR) levels in this group versus patients on anticoagulation for other indications.

Main Methods:

  • Retrospective chart review of 60 patients post-mechanical heart valve replacement.
  • Comparison with a control group of 100 patients receiving anticoagulation for atrial fibrillation, pulmonary embolism, or deep vein thrombosis.
  • Analysis of international normalized ratio (INR) on day 3 of warfarin therapy.

Main Results:

  • Patients post-mechanical heart valve replacement had a significantly higher mean INR (4.1+/-3.9) on day 3 compared to controls (1.9+/-0.7).
  • A wide range of INR values (1.1-17.1) was observed in the mechanical heart valve replacement group.
  • The difference in INR between the groups was statistically significant (p<0.05).

Conclusions:

  • Patients receiving warfarin after mechanical heart valve replacement exhibit heightened sensitivity to the anticoagulant.
  • Lower initial warfarin dosages might be required during the first three days post-valve replacement.
  • Further research into optimized dosing strategies for this patient population is warranted.

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...